Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Needham

EBay "Thesis Not Changing" Analysts Say After Strong Guidance, Mixed Earnings

Analysts are sizing up the second-quarter financial report from marketplace and auction company eBay Inc (NASDAQ: EBAY), which reported results Wednesday after market close. The eBay Analysts: Needham analyst Anna Andreeva had a Hold rating and no price target.

Benzinga

6 Amazon Analysts React To Q2 Earnings Report: 'Our Top '22 FANG Stock'

Amazon.com, Inc. (NASDAQ: AMZN) shares traded higher by 11.5% on Friday after the company reported impressive second-quarter numbers in a difficult macroeconomic climate.

Benzinga

Enterprise Software Firms Like Coursera, Five9, Teladoc Health And More Will 'Bake Looming Macro Slowdown Into Guidance,' Cautions This Analyst

Needham analyst Scott Berg shared 2Q earnings for its Enterprise Software universe kick-off this week with seven companies reporting, namely, 2U, Inc (NASDAQ: TWOU) (

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

8 Netflix Analysts React To Q2 Earnings Beat, Subscriber Guidance, Ad-Supported Tier

Netflix, Inc. (NASDAQ: NFLX) shares gained 7.1% on Wednesday after the company reported better-than-expected subscriber losses in the second quarter and detailed plans to launch a new, low-cost, ad-supported subscription tier.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2022

Upgrades

Benzinga

Needham Retains Conviction On DoorDash Despite Amazon's Collaboration With Rival Just Eat Takeaway.com

Needham analyst Bernie McTernan believes DoorDash, Inc (NYSE: DASH) can leverage its leadership position in restaurant delivery to become one of the leading, horizontal, on-demand, last-mile fulfillment providers in North America.

Benzinga

Read Why Needham Reiterated Buy On fuboTV Despite Slashing Its Price Target By 67%

Needham analyst Laura Martin saw fuboTV Inc (NYSE: FUBO) as an inexpensive way for public investors to participate in the U.S.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Needham Slashes Revenue, Earnings Projections, Price Targets of Majority Semiconductor Stocks: Key Takeaways

Needham analyst N. Quinn Bolton saw a slowdown in demand across most end markets coupled with several quarters of inventory purge is likely to significantly decrease semiconductor sales in C2H22 and 2023 from original base case estimates.

Benzinga

Needham Maintains Buy Rating for CarGurus: Here's What You Need To Know

Needham has decided to maintain its Buy rating of CarGurus (NASDAQ:CARG) and lower its price target from $40.00 to $32.00. Shares of CarGurus are trading up 0.42% over the last 24 hours, at $22.52 per share. A move to $32.00 would account for a 42.13% increase from the current share…

Benzinga

Here's Why Accolade Shares Are Trading Higher Today

Needham analyst Ryan MacDonald reiterated a Buy rating on Accolade, Inc (NASDAQ:ACCD) with a price target of $12. Following a problematic 4QF22, he noted that Accolade bounced back nicely in 1QF23 as the company beat management's initial outlook for FY23 revenue and adjusted EBITDA. While early in the selling season, ACCD won more new business in 1QF23 than…

Benzinga

TikTok's Smaller US Rival Files For IPO

Short video app Triller Inc has confidentially filed for an initial public offering with the U.S. SEC. Recently, Triller terminated its merger with video advertising software provider SeaChange International, Inc (NASDAQ:SEAC) when it shared plans to pursue an IPO with a potential listing under the ticker symbol "ILLR" by September. Also Read: Triller Merging With SeaChange International: What Investors Should…

Benzinga

Why Did Needham Lift Price Target For Trevi?

Yesterday Trevi Therapeutics Inc's (NASDAQ:TRVI) Phase 2b/3 trial (PRISM) evaluating Haduvio (nalbuphine ER) for prurigo nodularis (PN) successfully met the key primary and secondary endpoints. Needham writes that Haduvio had a quick onset of action, reaching stat sig at 6 weeks with efficacy that had yet to plateau at the wk-14 readout. Trevi…

Benzinga

Analysts Still Believe Verrica's Ycanth Is Approvable Despite FDA Response Letter

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) held a Type A meeting with the FDA regarding the path forward for the resubmission and potential approval of Ycanth (VP-102) for molluscum contagiosum. HC Wainwright says VP-102 was approvable, and at the time of the Complete Response Letter (CRL), Verrica had already engaged a potential alternate solution supplier. It reiterates…

Benzinga

Here's Why Needham Continues To See 105% Upside To Avalara Post Its Analyst Day

Needham analyst Scott Berg attended Avalara, Inc's (NYSE: AVLR) virtual analyst day, in which the company highlighted new products and provided intermediate-term financial targets that beat expectations.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Needham's Developer Checks For Wix.com Highlight Continued Funnel Weakness

Needham analyst Bernie McTernan reiterated a Buy rating and $85 price target on Wix.com Ltd (NASDAQ:WIX) following a round of web developer checks. He spoke with 22 developers in the WIX Marketplace to shed light on the broader funnel. They did not indicate any improvement. Failure of the funnel to return puts his 2H'22E and…

Benzinga

Thinking About Buying Stock Or Options In Robinhood Markets, Nio, Tesla Or Etsy?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends. Here are the latest analyst rating updates for Robinhood Markets, Nio, Tesla and Etsy:

Benzinga

Needham Remains Upbeat On DoorDash; Slashes Price Target By 29%

Needham analyst Bernie McTernan maintained DoorDash, Inc (NYSE:DASH) with a Buy rating and lowered the price target from $140 to $100 (42% upside). He believes DASH could leverage its leadership position in restaurant delivery to become one of the leading, horizontal, on-demand, last-mile fulfillment providers in North America. Ultimately, he thinks DASH would be able…

Benzinga

Analysts Hailed CarMax's Q1 Performance While Highlighting Concerns

Analysts lauded CarMax Inc's (NYSE:KMX) Q1 beat while also pointing out the macro concerns. RBC Capital analyst Steven Shemesh maintained CarMax with an Outperform and raised the price target from $104 to $108 in a note titled, "F1Q'23 Follow-Up – Navigating Volatility Well." KMX's results were broadly in line with expectations, Shemesh noted. He expected the inflationary…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022

Upgrades

Benzinga

Read Why Needham Is Bullish On This Pet Care Retailer

Needham analyst Anna Andreeva upgraded Chewy Inc (NYSE:CHWY) to Buy from Hold with a price target of $55, implying a 44% upside. The analyst said the company had exceeded expectations in Q1 FY22 after missing consensus EBITDA for four quarters. Andreeva thinks the positive momentum continued in Q2 as the pet category was inelastic, with price increases sticking,…

Benzinga

Etsy Shares Drop As Needham Downgrades Stock Citing Near-Term Risks

Needham analyst Anna Andreeva downgraded Etsy, Inc (NASDAQ:ETSY) from Buy to Hold. While shares have lagged and some near-term volatility is arguably in the stock, she views the discretionary nature of the ETSY model as increasingly at risk in the near term. While visibility is low, she thought that consensus GMS and Sales estimates…

Benzinga

Needham Is Bullish On This Botox Equivalent Aesthetics Company

Needham initiated coverage on Evolus Inc (NASDAQ:EOLS) with a price target of $18.00 (43% upside) and a Buy rating. Evolus is a pure-play aesthetics company focused on growing the presence of Jeuveau, its new neurotoxin product, in the approximately $3 billion global wrinkle treatment market. Jeuveau is a prescription medicine injected into muscles to improve…

Benzinga

Ad Industry's Biggest Conference Returns With New Winner: Find Out Who

The advertising industry's biggest conference has returned with a new winner Amazon.com, Inc (NASDAQ: AMZN), after a two-year break, Bloomberg reports. Amazon occupied a portion of the beachfront at the annual Cannes Lions show with the "Amazon Port," its most extensive showcasing at the conference yet reflecting its growing significance. Tech companies like Alphabet Inc (NASDAQ:GOOG)…

Benzinga

Needham Expresses Bullishness On US Ride-Share Industry; Uber Remains On Conviction List

Needham analyst Bernie Mcternan forecasted a 24% 3-year CAGR for U.S. ride-share bookings through 2025, down from the 45% CAGR in the three years heading into the pandemic. Company data, industry reports, and a proprietary survey of 500+ U.S. consumers supported the forecast.

Benzinga

Here's Why Needham Predicts Taboola Shares To Double

Needham analyst Laura Martin reiterated Buy on Taboola.com Ltd (NASDAQ:TBLA) with a price target of $5 (95.3% upside). Martin cited the eMarketer report that advertising revenue on the Open Internet (excluding Walled Gardens like Amazon.com Inc (NASDAQ: AMZN), Meta Platforms Inc's (NASDAQ:META) Facebook, Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google, YouTube, Snap Inc (NYSE:SNAP), and Roku, Inc (NASDAQ:ROKU)) is about $40 billion in the U.S. and about…

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations